HemaSphere (Jun 2022)

P692: IMMUNE FACTORS MAINTAINING TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF IMATINIB

  • P. Kwaśnik,
  • J. Zaleska,
  • D. Link-Lenczowska,
  • M. Zawada,
  • B. Ochrem,
  • G. Bober,
  • E. Wasilewska,
  • E. Mędraś,
  • I. Hus,
  • M. Szarejko,
  • W. Prejzner,
  • O. Grzybowska-Izydorczyk,
  • A. Klonowska-Szymczyk,
  • T. Sacha,
  • K. Giannopoulos

DOI
https://doi.org/10.1097/01.HS9.0000845652.56752.23
Journal volume & issue
Vol. 6
pp. 587 – 588

Abstract

Read online

No abstracts available.